All of the latest secondary stock offerings, posted as they are announced, from The of 4,615,385 shares of its common stock, offered at a price of $6.50 per share to the public. Company: Applied Genetic Technologies Corporation ( AGTC)

Applied Genetic Technologies Co (AGTC) Stock Price, Quote ... Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that it has completed enrollment in the two highest dose groups of its Phase 1/2 clinical trial evaluating the safety and efficacy of Applied Genetic Technologies News | Markets Insider Is Applied Genetic Technologies (AGTC) Stock Outpacing Its Medical Peers This Year? Zacks 240d AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2019 Applied Genetic Technologies (NASDAQ:AGTC) Rating ... Applied Genetic Technologies (NASDAQ:AGTC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The brokerage currently has a $3.50 target price on the biotechnology company’s stock. Applied Genetic Technologies (AGTC) Jumps: Stock Up 6.1% ...

Zacks Investment Research Lowers Applied Genetic ...

AGTC - Applied Genetic Tech Stock Price - Barchart.com Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, Applied Genetic Technologies Corp. - NASDAQ:AGTC - Stock ... View detailed financial information, real-time news, videos, quotes and analysis on Applied Genetic Technologies Corp. (NASDAQ:AGTC). Explore commentary on Applied Genetic Technologies Corp. and AGTC - Applied Genetic Summary, Stock Quote and News ...

Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that it has completed enrollment in the two highest dose groups of its Phase 1/2 clinical trial evaluating the safety and efficacy of

Applied Genetic Technologies Co (AGTC) Stock Price, Quote ... Find the latest Applied Genetic Technologies Co (AGTC) stock quote, history, news and other vital information to help you with your stock trading and investing. Zacks. All You Need to Know AGTC - Developing Groundbreaking At AGTC we are developing genetic therapies to treat patients with rare inherited conditions. Our most advanced therapy programs are designed to restore visual function and meet the needs of patients with rare blinding conditions. Learn more AGTC: Applied Genetic Technologies Corporation - Brokerage ... AGTC: Applied Genetic Technologies Corporation broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research.

Applied Genetic Technologies (AGTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy). Enrollment ongoing in pediatric

Applied Genetic Technologies (AGTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy). Enrollment ongoing in pediatric AGTC: Applied Genetic Technologies Corporation - Greek ... The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style. We produce five unique ratings, including the Zacks Style Score, … AGTC Stock | APPLIED GENETIC TECHNOLOGIES Stock Price ...

Jan 01, 2010 · Applied Genetic (NASDAQ: AGTC) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on

Applied Genetic Technologies (AGTC) Reports Q4 Loss, Lags ... Sep 26, 2019 · Applied Genetic Technologies (AGTC) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.51. … Implied Volatility Surging for Applied Genetic ... Jan 10, 2020 · Investors in Applied Genetic Technologies Corporation AGTC need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 21, 2020 $7.50 Call had some of the highest implied volatility of all equity options today.

AGTC - Applied Genetic Tech News - Barchart.com Applied Genetic Tech (AGTC) Applied Genetic Tech (AGTC) [[ item.lastPrice ]] Applied Genetic Stock Up on Favorable Eye Therapy Study Data Zacks Equity Research - Zacks Investment Research - Fri Jan 10, 9:08AM CST. Zacks Equity Research - ZACKS - Fri Jan 10, 9:08AM CST. Applied Genetic Technologies (AGTC) Reports Q4 Loss, Lags ... Sep 26, 2019 · Applied Genetic Technologies (AGTC) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.51. … Implied Volatility Surging for Applied Genetic ... Jan 10, 2020 · Investors in Applied Genetic Technologies Corporation AGTC need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 21, 2020 $7.50 Call had some of the highest implied volatility of all equity options today.